Unlocking AI’s potential in drug discovery: A roadmap to scalable solutions
Drug Discovery World
SEPTEMBER 9, 2024
Dr Mutlu Dogruel, Vice President of AI Solutions at Cresset, examines AI’s transformative potential, highlights the current challenges and introduces a series of potential solutions to implement AI in the drug discovery landscape successfully. The use of artificial intelligence (AI) is creating a paradigm shift in drug discovery and optimisation processes, allowing for the analysis of large-scale datasets, the design of new molecules, and the prediction of drug properties more efficiently.
Let's personalize your content